NanoString Technologies Inc (NSTG.OQ)
9.28USD
20 Apr 2018
$-0.27 (-2.83%)
$9.55
$9.49
$9.59
$9.26
26,822
62,151
$19.28
$5.87
Thu, Mar 8 2018
BRIEF-Nanostring Technologies Reports Q4 Loss Per Share $0.34
* NANOSTRING TECHNOLOGIES RELEASES FOURTH QUARTER AND FULL YEAR 2017 OPERATING RESULTS AND PROVIDES 2018 OUTLOOK
BRIEF-Nanostring Technologies Q4 Loss Per Share $0.34
* NANOSTRING TECHNOLOGIES RELEASES FOURTH QUARTER AND FULL YEAR 2017 OPERATING RESULTS AND PROVIDES 2018 OUTLOOK
BRIEF-Nanostring Appoints Thomas Bailey As CFO
* NANOSTRING APPOINTS THOMAS BAILEY AS CHIEF FINANCIAL OFFICER
BRIEF-Nanostring Technologies Signs Sales Agreement With Cowen And Co
* NANOSTRING TECHNOLOGIES SIGNS SALES AGREEMENT WITH COWEN AND CO RELATING TO COMMON STOCK OFFERING OF UP TO $40 MILLION - SEC FILING Source text (http://bit.ly/2CPZkbR) Further company coverage:
BRIEF-NanoString And RikenGenesis Announce Partnership To Commercialize Ncounter-Based Diagnostic Assays In Japan
* NANOSTRING AND RIKENGENESIS ANNOUNCE PARTNERSHIP TO COMMERCIALIZE NCOUNTER-BASED DIAGNOSTIC ASSAYS IN JAPAN
BRIEF-Nanostring Technologies reports Q3 loss per share $0.45
* Nanostring Technologies Inc releases operating results for third quarter of 2017
BRIEF-Nanostring and NSABP Foundation enter into agreement to study immunophenotypes in colorectal cancer
* Nanostring and NSABP foundation enter into agreement to study immunophenotypes in colorectal cancer Source text for Eikon: Further company coverage:
- Week 16 Breakout Forecast: Short-Term Picks To Give You An Edge
- Week 15 Breakout Forecast: Short-Term Picks To Give You An Edge
- NanoString's (NSTG) CEO Brad Gray on Q4 2017 Results - Earnings Call Transcript
- NanoString (NSTG) Presents At 36th Annual J.P. Morgan Healthcare Conference - Slideshow
- NanoString Technologies' (NSTG) CEO Brad Gray on Q3 2017 Results - Earnings Call Transcript
- Your Daily Pharma Scoop: A Seeking Alpha Interview, Spark AdCom Nod For Luxturna, Pfizer LYRICA Approval